Drug intelligence / Profile preview

RegenoGel

Development stage
Phase 4
Lead developer
ProCore Bio
Modality
Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
Administration
Intraarticular
01

Overview

RegenoGel is a novel intra-articular viscosupplement and regenerative scaffold developed by ProCore Ltd for the treatment of knee osteoarthritis. It consists of high molecular-weight hyaluronic acid (HA) chemically conjugated to fibrinogen using the proprietary HaProlink technology. Upon injection into the joint and activation by thrombin or tissue factors, the conjugate assembles into a solid, insoluble fibrin-HA hydrogel. This hydrogel provides mechanical protection, enhances viscosupplementation, and serves as a bioactive scaffold to promote stem cell attachment and tissue regeneration. The product exists in two forms: RegenoGel, which utilizes purified human plasma-derived fibrinogen, and RegenoGel-OSP, which utilizes autologous plasma-derived fibrinogen.

Brand names
RegenoGel
Other names
RegenoGel-OSPfibrin-hyaluronan hydrogelfibrin-HA conjugate

Beyond the preview

Go deeper on RegenoGel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RegenoGel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call